dihexa administration oral subcutaneous Peptide Therapy Dihexa: A Comprehensive Guide to

22.9%, P =0.01)

Soldovieri MV, Freri E, Ambrosino P, Rivolta I, Mosca I, Binda A, Murano C, Ragona F, Canafoglia L, Vannicola C, Solazzi R, Granata T, Castellotti B, Messina G, Gellera C, Labalme A, Lesca G, DiFrancesco JC, Taglialatela M (2020) Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy

Significant findings at the initial evaluation: Right hip pain, deep ache (1/10) to sharp pain (8/10) Pain with hurdling and hip flexion Positive scour test and FABER test (minimal) Internal rotation was within normal limits Weak glutes and intrinsic core After 3 visits in 4 weeks, the patient reported 70% improvement of symptoms

Labral damage indicates ongoing impingement and rarely occurs alone. (10) Deeper dive: Chiroup subscribers can visit the Clinical Skills tab for a comprehensive review of best practices for diagnosing and managing FAI

Retrieved July 25, 2020 via MLive